I smell something brewing. When you have a 12 cent stock with a 90 million market cap listed with companies that have over 100 billion in market cap the future is bright. Are we going to get a billion dollar market cap over night? No, but in 5 years there is no telling where this company will be. Lympro is a nice beginning with high demand and accessible markets. I think MANF and orphan drug statuses are the kingpins. When MANF is ready for prime time, which I am assuming is in 3-5 years, the market cap might be in the ten's of billions. Don't let shorts and bashers distract. All those companies have over a billion shares outstanding. What Gerald an Company are advocating for isn't out of the ordinary when it comes to bio- techs.